pete_nash said:Amycretin (AMY/GLP-1 dual agonist) emerging data relevant to the pharmacology: Phase 1 showed -13.1% body weight at only 12 weeks, the fastest…
Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.
Correct me if the detail matters more than I have assumed.